about
Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trialsHuperzine A for mild cognitive impairmentNew Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapiesTherapy for Alzheimer's Disease: How Effective are Current Treatments?Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementiaA systematic review of single chinese herbs for Alzheimer's disease treatment.Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use DisorderPharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke.Old and new acetylcholinesterase inhibitors for Alzheimer's disease.Herbal therapy: a new pathway for the treatment of Alzheimer's diseaseThe clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial.
P2860
Q21090712-54F83D4B-916D-43AC-A5AF-35302A747627Q24202101-8DC4BA41-1502-4D67-B14C-167D0FDE1638Q30393882-76393CFD-1C38-4FE7-BFF8-EF850675176FQ30560766-1F275047-1122-4863-B850-99AA5D494E7CQ33726281-661EFB85-805B-4265-BEBB-450C8E91188FQ33797803-A76F5F0B-5090-4C81-A193-C670CF36DF2CQ34409349-9E677700-924E-44AF-8028-A2959FB1252AQ34989295-6C2637E0-049D-43DA-B4D9-F1EB710616E2Q35106666-9D0431FF-DE11-462D-BCC7-60130FFEC576Q35256535-85BBFFB0-D543-433A-AC0A-30DC077BF6F3Q36274037-03F9DD1F-5CFB-442E-A063-5F37A64A0456Q36749831-3DA4F401-2233-4083-AD5A-78FCAB028BBFQ37508249-8131C18D-DAFF-4947-ACE0-65FE4931E9B7Q37594755-260297AF-F511-4C6C-9CFB-B7C47DBF1EC5Q37668019-71E7D44F-B6F3-44CC-9664-9BAC01297A9DQ38908823-B80D8385-0C6D-4CFC-AFC2-E53C2AF89C58Q39818663-0E9929FD-EED8-4255-86BE-9BE96232CE30Q47549748-8671C81B-7F26-428B-AEB4-3225F730CA40
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Huperzine A for Alzheimer's disease
@ast
Huperzine A for Alzheimer's disease
@en
Huperzine A for Alzheimer's disease
@en-gb
Huperzine A for Alzheimer's disease
@nl
type
label
Huperzine A for Alzheimer's disease
@ast
Huperzine A for Alzheimer's disease
@en
Huperzine A for Alzheimer's disease
@en-gb
Huperzine A for Alzheimer's disease
@nl
prefLabel
Huperzine A for Alzheimer's disease
@ast
Huperzine A for Alzheimer's disease
@en
Huperzine A for Alzheimer's disease
@en-gb
Huperzine A for Alzheimer's disease
@nl
P2093
P2860
P1476
Huperzine A for Alzheimer's disease
@en
P2093
Guan Jian Liu
Hong Mei Wu
Rongle L Zhou
P2860
P304
P356
10.1002/14651858.CD005592.PUB2
P407
P50
P577
2008-04-23T00:00:00Z